Understanding the mechanisms behind cystic fibrosis infections

Cystic fibrosis is a genetic disease that causes serious and sometimes fatal respiratory and digestive disorders. A new treatment, available since 2020, improves lung function and quality of life. However, it does not always eradicate the bacteria responsible for respiratory infections. By studying 3D models of human lung cells, scientists at the University of Geneva (UNIGE) discovered that this drug does not prevent the development on the surface of the respiratory tract of ”docking stations” to which bacteria attach themselves to infect the body. These docking stations result from a disruption in the signals involved in cell development in the respiratory system. By combining the current treatment with other molecules, it may be possible to restore cell balance and thus better prevent bacterial infections. These results are published in the American Journal of Respiratory Cell and Molecular Biology.


Cystic fibrosis is the most common genetic disease. Each year, it affects one in every 3,300 newborns in Switzerland. Mutations in the gene responsible for the CFTR protein cause the secretion of excessively thick mucus, which obstructs the airways. Although a triple therapy, available in Switzerland since 2020, has improved the quality of life of people with cystic fibrosis, it is not suitable for all those affected and does not always prove effective.

”A significant proportion of people who take this treatment still suffer from residual inflammation and persistent respiratory infections. Understanding the reasons for this is essential if we are to improve patient care,” explains Marc Chanson, full professor in the Department of Cell Physiology and Metabolism in the UNIGE Faculty of Medicine and member of the Geneva Inflammation Research Centre, who led this research.

An imbalance in cell signals

In previous studies, Marc Chanson’s team had discovered that respiratory cells affected by cystic fibrosis build on their surface docking stations that enable bacteria to firmly anchor to the lungs. ”We therefore wanted to find out whether triple therapy had an effect on this mechanism, which is so predisposing to bacterial infection,” explains Mehdi Badaoui, research and teaching fellow in the Department of Cell Physiology and Metabolism in the UNIGE Faculty of Medicine and last author of the study.

By comparing 3D models of human lung cells — healthy cells as well as cells with cystic fibrosis — the scientists demonstrated that the triple therapy currently used does not prevent the formation of these docking stations. Indeed, gene expression in healthy cells, compared with cystic fibrosis cells, shows an imbalance between two cell signalling pathways: the TGF-β pathway is hyperactivated, while the Wnt pathway is inhibited. Cell signalling pathways underpin the development of all multi-cellular organisms, including humans. Without them, cells are unable to develop and function properly.

By revealing a disruption in these signalling pathways, the research team shed light on a key mechanism: diseased cells do not receive appropriate signals and react by creating docking stations that are harmful to them. By restoring the balance between these two cell signalling pathways, the scientists were able to significantly reduce the development of these structures.

If we manage to identify a pharmaceutical compound capable of restoring this balance in patients, we could then combine it with the current triple therapy to increase its efficacy and limit bacterial infections, while reducing its side effects.”

Marc Chanson, full professor in the Department of Cell Physiology and Metabolism in the UNIGE Faculty of Medicine

Source:Journal reference:Idris, T., et al. (2024). Akt-driven TGF-β and DKK1 Secretion Impairs F508del CF Airway Epithelium Polarity. American Journal of Respiratory Cell and Molecular Biology. doi.org/10.1165/rcmb.2023-0408oc.


Explore more

Stop Letting Others Control Your Life

Stop Letting Others Control Your Life

SUMMARY: In this episode, Brendon teaches… How to focus more on positive life outcomes like life satisfaction, fitness, happiness, and confidence is essential. Why better embracing significant...

You Asked: In a Woman with ADHD, Should You Continue Treatment...

Question: I have a 32-year-old patient with ADHD who stopped her stimulant medication (Concerta 54 mg) during pregnancy. She is now at 34 weeks of...

The Future of Period Pain Relief

Hey there, womanhood warriors! We get you, and we especially get you on those days of the month. Period cramps are a real problem...
Preventive Care: How It Can Save Your Business Money On Health Insurance

Preventive Care: How It Can Save Your Business Money On Health...

As a small business owner in California or Arizona, you already understand the importance of keeping your employees healthy and productive. But you also...

Biosensor technology company Allez Health secures $60M

California-based Allez Health, formerly Zense-Life, announced it secured $60 million in Series A+ financing.  The round was led by strategic investor Osang Healthcare, with participation...
Omega-3 index test

Omega-3 index test and benefits for overall health and well-being

The Omega-3 Index test...
Thousands of NÜTRL tumblers recalled after dozens report illness - National

Thousands of NÜTRL tumblers recalled after dozens report illness – National

A promotional NÜTRL branded tumbler that was recalled in Canada earlier this month caused multiple reports of adverse health effects, an updated notice said...
Dentistry procurement platforms and trends 2024

E-Procurement Platforms, AI, and More Trends from DentalForum 2024

This article was written by the Planet DDS staff and originally published on DrBicuspid.com.At this year’s DentalForum, leaders from more than two dozen dental...